This study presents a framework to evaluate rare and de novo variation from whole-genome sequencing (WGS). The work suggests that robust results from WGS studies will require large cohorts and strategies that consider the substantial multiple-testing burden.
- Donna M. Werling
- Harrison Brand
- Stephan J. Sanders
